Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Clear all

264 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20028
200317
200412
200515
200614
200712
200812
200921
201011
201120
201212
201322
20147
201510
20162
20173
201810
20193
20204
20215
20224
20234
20248
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed168
Unknown status35
Terminated28
Active, not recruiting8
Recruiting8
Not yet recruiting7
Withdrawn7
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation15
Cordis US Corp.12
Abbott Medical Devices6
AstraZeneca6
National Heart, Lung, and Blood Institute (NHLBI)6
Assistance Publique - Hôpitaux de Paris4
Gilead Sciences4
University of Patras4
Acusphere3
Bayer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease264
Myocardial Ischemia32
Heart Diseases22
Acute Coronary Syndrome21
Coronary Disease19
Myocardial Infarction18
Cardiovascular Diseases17
Angina Pectoris14
Coronary Stenosis12
Atherosclerosis11

Trials

Showing 76 to 100 of 264. Each trial links to its page on Pharma Observatory.

164 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.